| [1]Long HM, Parsonage G, Fox CP, et al. Immunotherapy for Epstein-Barr virus-associated malignancies [J]. Drug News Perspect, 2010, 23(4):221-228.[2]Maniar A, Zhang X, Lin W, et al. Human γδT lymphocytes induce robust NK cell mediated antitumor cytotoxicity through CD137 engagement [J]. Blood, 2010, 116(10):1726-1733.[3]Reschner A, Hubert P, Delvenne P, et al. Innate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune response [J]. Clin Exp Immunol, 2008, 152(2):219-226.[4]Brandes M, Willimann K, Bioley G, et al. Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses [J]. Proc Natl Acad Sci USA, 2009, 106(7):2307-2312.[5]Kabelitz D, Wesch D, He W. Perspectives of gammadelta T cells in tumor immunology [J]. Cancer Res, 2007, 67(1):5-8.[6]Moser B, Eberl M. γδT-APCs: a novel tool for immunotherapy [J]? Cell Mol Life Sci, 2011, 68(14):2443-2452.[7]Maeurer MJ, Martin D, Walter W, et al. Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin [J]. J Exp Med, 1996, 183(4):1681-1696.[8]Poggi A, Venturino C, Catellani S, et al. Vδ1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid [J]. Cancer Res, 2004, 64(24):9172-9179.[9]Sireci G, Espinosa E, Di Sano C, et al. Differential activation of human gammadelta cells by nonpeptide phosphoantigens [J]. Eur J Immunol, 2001, 31(5):1628-1635.[10]Zhou J, Kang N, Cui L, et al. Anti-γδ TCR antibody-expanded γδ T cells: a better choice for the adoptive immunotherapy of lymphoid malignancies [J]. Cell Mol Immunol, 2011[2011-06-13]. http://www.nature.com/cmi/journal/vaop/ ncurrent/full/cmi201116a.html.[11]Flescher E, Fingrut O. Suppression of interleukin 2 biosynthesis by three modes of oxidative cellular stress: selective prevention by N-acetyl cysteine [J]. Cytokine, 2000, 12(5):495-498.[12]Yim CY, Hibbs JB Jr, McGregor JR, et al. Use of N-acetyl cysteine to increase intracellular glutathione during the induction of antitumor responses by IL-2 [J]. J Immunol, 1994, 152(12):5796-5805. |
Acta Academiae Medicinae Sinica
